Science and technology

Researchers develop cryogenic brain implant to treat epilepsy

28 October 20265 min read

Researchers develop cryogenic brain implant to treat epilepsy
A prototype brain implant combining electrical activity recording and local cooling to resist focal seizures.

Innovative prototype

German and British researchers have developed a prototype of a brain implant manufactured using 3D printing technology, which combines recording brain electrical activity with targeted local cooling, in an experimental technique aimed at contributing to the development of new methods for dealing with drug-resistant focal seizures.

International scientific collaboration

The website "Medical Xpress" reported on Tuesday that the implant was developed by researchers from the Leibniz Institute for Polymer Research and the Elsbeth Kroner Fresenius Center for Digital Health at the Technical University of Dresden in Germany, in collaboration with researchers from the University of Sheffield in the UK, and the study results were published in the journal "Advanced Science".

Advanced components and technology

The implant combines electronic components, flexible silicon structures, and fluid transfer channels, allowing for monitoring of brain electrical activity and applying cooling in a specific area, within a single integrated device, while an auxiliary control unit enables control and monitoring of both recording and cooling processes.

Promising experimental results

Initial tests, which included computer simulations and tissue-mimicking models, showed the system's ability to provide rapid and stable local cooling. Animal model experiments for epilepsy also demonstrated that 3D-printed electrodes recorded cortical activity with quality comparable to a commercial system, while local cooling contributed to suppressing experimentally induced seizure-like neural activity.

Current research stage

Researchers hope that combining electrical activity monitoring with targeted cooling will enable the development of implants capable of responding to abnormal neural activity in the future. However, the technology remains in the experimental stage and requires further studies to evaluate its safety and efficacy before clinical testing.

Source: Syrian Arab News Agency (SANA)

Comments (0)

0 / 600
No comments yet. Be the first to comment.